Arti-cell Forte stem cell-based veterinary product
Boehringer Ingelheim launches the first-ever registered stem cell-based veterinary medicineEuropean Commission has granted marketing authorisation for the first stem cell-based product in animal healthArti-Cell ® Forte is a unique ready-to-use solution for the treatment of equine lamenessThe partnership of Boehringer Ingelheim and GST proves its commitment to bring highly innovative therapeutics for horses to customers
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news
More News: Marketing | Partnerships | Research | Stem Cell Therapy | Stem Cells | Veterinary Research